The Pharmacy Times® Immunization Resource Center is a comprehensive resource for clinical news and expert insights on common immunizations, such as flu, zoster, and COVID-19 vaccines.
September 16th 2025
Misinformation is fueling parental fears and a concerning drop in childhood vaccines.
Large Burden of Community-Acquired Pneumonia Hospitalizations Among Older US Adults
August 8th 2025Older adults in the United States continue to be burdened with disproportionate rates of community-acquired pneumonia hospitalizations, including due to serotypes covered in the recently approved V116 vaccine.
Read More
Pharmacists Can Tackle Thimerosal Misinformation Through Education, Empathy, and Transparency
July 23rd 2025Adam James, PharmD, and Chris Altman, PharmD, explain how pharmacists can build trust and reduce vaccine hesitancy by clearly communicating thimerosal’s limited role in today’s immunizations and addressing patient concerns with empathy and education.
Watch
Pharmacists Address Thimerosal's Role, Safety, and ACIP's Updated Flu Vaccine Recommendation
July 15th 2025Adam James, PharmD, and Chris Altman, PharmD, discuss renewed public scrutiny of thimerosal, its limited use in vaccines today, and how new guidance may affect pharmacists and patient confidence moving forward.
Watch
Pharmacies Lead the Way in Vaccine Equity and Access With Scalable, Sustainable Models
July 10th 2025Annie Eisenbeis, PharmD, MBA, showcased how Missouri’s Pharmacy Vaccine Gap Closure Program is transforming pharmacy-based immunization services through scalable workflows, team training, and a redefined role for pharmacy technicians as community health workers.
Read More
FDA Grants Full Approval to mRNA-1273 COVID-19 Vaccine in Children at Increased Risk
Published: July 10th 2025 | Updated: July 10th 2025mRNA-1273, marketed as Spikevax by Moderna, is now fully approved for individuals aged 6 months through 64 years with high-risk features for severe COVID-19.
Read More
Thimerosal Reenters Public Debate as ACIP Scrutinizes Use in Influenza Vaccines
June 27th 2025With the Advisory Committee on Immunization Practices recommending that adults receive thimerosal-free influenza vaccines, the preservative that was phased out of most childhood vaccines in 2001 has reentered the public eye.
Read More
ACIP Recommends Adults Receive Seasonal, Single-Dose Influenza Vaccines Free of Thimerosal
June 26th 2025The Advisory Committee on Immunization Practices (ACIP) voted 5-1, with 1 voter abstaining, to recommend that adults receive seasonal influenza vaccines that do not contain the preservative thimerosal.
Read More